Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1438.75
-2.95 (-0.20%)
< Home < Back

Cipla signs definitive agreement to acquire stake in subsidiary

Date: 07-08-2019

Cipla has signed definitive agreement to acquire the minority stake of Eight Roads Investment Mauritius II in its subsidiary -- Cipla Health. The transaction is expected to be completed within a month.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.